Display options
Share it on

Clin Pharmacol. 2014 Jul 12;6:103-6. doi: 10.2147/CPAA.S66776. eCollection 2014.

Effect of age and sex on warfarin dosing.

Clinical pharmacology : advances and applications

Ghada Khoury, Marwan Sheikh-Taha

Affiliations

  1. School of Pharmacy, Lebanese American University, Byblos, Lebanon.
  2. Department of Pharmacy Practice, Lebanese American University, Byblos, Lebanon.

PMID: 25050078 PMCID: PMC4103915 DOI: 10.2147/CPAA.S66776

Abstract

OBJECTIVE: We examined the potential effect of sex and age on warfarin dosing in ambulatory adult patients.

METHODS: We conducted a retrospective chart review of patients attending an anticoagulation clinic. We included patients anticoagulated with warfarin for atrial fibrillation or venous thromboembolism who had a therapeutic international normalized ratio of 2-3 for 2 consecutive months. We excluded patients who had been on any drug that is known to have a major interaction with warfarin, smokers, and heavy alcohol consumers. Out of 340 screened medical records, 96 met the predetermined inclusion criteria. The primary outcome assessed was warfarin total weekly dose (TWD).

RESULTS: There was a statistically significant difference in the TWD among the ages (P<0.01); older patients required lower doses. However there was no statistically significant difference in the TWD between sexes (P=0.281).

CONCLUSION: Age was found to have a significant effect on warfarin dosing. Even though women did require a lower TWD than men, this observation was not statistically significant.

Keywords: INR; age; anticoagulation; vitamin K antagonists; warfarin

References

  1. Br J Clin Pharmacol. 1977 Jun;4(3):315-20 - PubMed
  2. Clin Cornerstone. 2005;7(4):49-56 - PubMed
  3. J Pharm Pract. 2010 Jun;23(3):194-204 - PubMed
  4. Pharmacogenomics. 2007 Apr;8(4):329-37 - PubMed
  5. J Clin Pharmacol. 2002 Feb;42(2):145-50 - PubMed
  6. Free Radic Biol Med. 1996;20(3):483-8 - PubMed
  7. Eur J Neurol. 2009 Oct;16(10):1100-5 - PubMed
  8. Clin Pharmacokinet. 1976;1(4):280-96 - PubMed
  9. Chest. 2005 Jun;127(6):2049-56 - PubMed
  10. Pharmacogenomics. 2007 Nov;8(11):1545-50 - PubMed
  11. Ann Intern Med. 1992 Jun 1;116(11):901-4 - PubMed
  12. Ann Pharmacother. 2002 Oct;36(10):1512-7 - PubMed
  13. Clin Pharmacokinet. 1998 May;34(5):359-73 - PubMed
  14. Thromb Haemost. 2004 Jan;91(1):87-94 - PubMed
  15. Am J Health Syst Pharm. 2005 May 15;62(10):1062-6 - PubMed
  16. Int J Hematol. 2003 Jul;78(1):84-6 - PubMed
  17. Br Med Bull. 1990 Jan;46(1):22-35 - PubMed
  18. Clin Pharmacol Ther. 2010 Jun;87(6):727-34 - PubMed
  19. Clin Pharmacol Ther. 1997 Mar;61(3):331-9 - PubMed
  20. Chest. 2008 Jun;133(6 Suppl):160S-198S - PubMed
  21. J Gerontol A Biol Sci Med Sci. 1998 Sep;53(5):B315-20 - PubMed
  22. J Clin Pathol. 1992 Aug;45(8):704-6 - PubMed
  23. Ther Clin Risk Manag. 2007 Jun;3(3):499-504 - PubMed

Publication Types